Zytiga, Stelara Lift Johnson & Johnson's Sales

It's hard to find a broader-based healthcare company than Johnson & Johnson (NYSE: JNJ). With exposure to everything from the most sophisticated medical devices and specially formulated prescription drug treatments to the items you've been buying off of drugstore shelves for years, J&J has its hand in everything related to healthcare.

Despite taking a substantial one-time tax hitdue to recent changes in the tax laws, Johnson & Johnson has been able to produce solid earnings even with some of its most successful treatments having lost patent protection and seeing a falloff in sales.